We are live on ! Find out more
TWST icon

Twist Bioscience

201 hedge funds and large institutions have $957M invested in Twist Bioscience in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 75 increasing their positions, 45 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 45

54% more call options, than puts

Call options by funds: $4.69M | Put options by funds: $3.05M

29% more capital inflows, than outflows

Capital inflows: $224M | Capital outflows: $173M

17% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 30

3.91% more ownership

Funds ownership: 107.46% → 111.37% (+3.9%)

2% more funds holding

Funds holding: 198 → 201 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
201
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
35
Increased
75
Reduced
45
Closed
30
Calls
$4.69​M
Puts
$3.05​M
Net Calls
+$1.64​M
Net Calls Change
+$723​K

TWST Hedge Fund Activity: Q1 2023 in Review

201 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q1 2023, worth a combined $957M — down 34% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new TWST positions and 30 closed out — a net gain of 5 holders — while 75 added to existing stakes and 45 trimmed.

The largest buyer was State Street, adding an estimated $18.8M. The largest seller was VOYA Investment Management, cutting an estimated $34.2M.

  • 201 institutional investors held Twist Bioscience (TWST) as of Q1 2023, up from 198 in Q4 2022.
  • Funds reported $957M of Twist Bioscience stock for Q1 2023, down 34% quarter-over-quarter.
  • 35 funds opened new Twist Bioscience positions in Q1 2023 and 30 closed out, a net change of +5 holders.
  • The largest Twist Bioscience buyer in Q1 2023 was State Street, an estimated $18.8M added.
  • The largest Twist Bioscience seller in Q1 2023 was VOYA Investment Management, an estimated $34.2M sold.

Based on aggregated 13F filings for Q1 2023.